Barraquer-Simons Syndrome

  • Sep 07, 2018 www.fitchsolutions.com
    European Drug Approvals Will Continue To Trail US – Fitch Solutions
    Read More
  • Jul 31, 2018 globenewswire.com
    Novelion Therapeutics Announces Marketing Authorization for MYALEPTA® (metreleptin) in the European Union to Treat Generalized and Partial Lipodystrophy – GlobeNewswire
    Read More
  • Jun 01, 2018 www.medscape.com
    EMA Panel Recommends Metreleptin for Leptin Deficiency – Medscape
    Read More
  • Jun 01, 2018 globenewswire.com
    MYALEPTA® (metreleptin) Receives Positive CHMP Opinion in Patients with Generalized and Partial Lipodystrophy – GlobeNewswire
    Read More

Connect. Empower. Inspire.